🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sarah Feldman

Brigham and Women's Hospital

ORCID: 0000-0002-5582-9401

Also affiliated with Parkland Health & Hospital System, Harvard University, Chicago Department of Public Health, McGill University Health Centre, Massachusetts General Hospital, National Cancer Institute, McGill University

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.2Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings

American Journal of Preventive Medicine(2023)10.1016/j.amepre.2023.04.016
Top 8%
2.7DataRank
Top 8%88 citations

Jane J. Kim, Jasmin A. Tiro, Sarah Feldman, Sarah C. Kobrin, Celette Sugg Skinner +7 more

Papers

Driven by 12 papers — median percentile 49. Top paper: “Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings”.

Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings

American Journal of Preventive Medicine(2023)10.1016/j.amepre.2023.04.016
Top 8%
2.7DataRank
Top 8%88 citations

Jane J. Kim, Jasmin A. Tiro, Sarah Feldman, Sarah C. Kobrin, Celette Sugg Skinner +7 more

Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record

O&G Open(2024)10.1097/og9.0000000000000032
Top 51%
0.342DataRank
Top 51%8 citations

Jacquelyn M. Lykken, Jasmin A. Tiro, Jessica Chubak, Jennifer S. Haas, Claudia L. Werner +5 more

Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.109
Top 66%
0.186DataRank
Top 66%2 citations

Jane Kim, Lei Wang, Jasmin A. Tiro, Sarah Feldman, Aruna Kamimeni +4 more

Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems

Preventive Medicine Reports(2023)10.1016/j.pmedr.2023.102279
N/A
0DataRank · unranked
1 citations

Jasmin A. Tiro, Ellen Hu, Sarah Ehsan, Jessica Chubak, Aruna Kamineni +6 more

Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems

Preventive Medicine Reports(2024)10.1016/j.pmedr.2024.102783
N/A
0DataRank · unranked
1 citations

Gaia Pocobelli, Steven J. Atlas, Cheryl R. Clark, Sarah Feldman, Gina Kruse +7 more

Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results

Journal of General Internal Medicine(2024)10.1007/s11606-024-08943-z
N/A
0DataRank · unranked
3 citations

Meghan L. Rieu‐Werden, Sarah C. Kobrin, Jasmin A. Tiro, Claudia L. Werner, Jacquelyn M. Lykken +9 more

Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1564
N/A
0DataRank · unranked
2 citations

Meghan L. Rieu‐Werden, Jacquelyn M. Lykken, Claudia L. Werner, Sarah Feldman, Michelle I. Silver +5 more

Guideline-Concordant Surveillance After Treatment for High-Grade Cervical Dysplasia

Obstetrics and Gynecology(2025)10.1097/aog.0000000000005877
N/A
0DataRank · unranked
3 citations

Jacquelyn M. Lykken, Jasmin A. Tiro, Rebecca B. Perkins, Jennifer S. Haas, Claudia L. Werner +3 more

Factors associated with timely colposcopy following an abnormal cervical cancer test result

Preventive Medicine(2022)10.1016/j.ypmed.2022.107307
N/A
0DataRank · unranked
16 citations

Jacquelyn M. Lykken, Jennifer Scarlet Haas, Claudia L. Werner, Sarah C. Kobrin, Jasmin A. Tiro +3 more

Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings

JAMA Network Open(2025)10.1001/jamanetworkopen.2024.54969
N/A
0DataRank · unranked
2 citations

Jacquelyn M. Lykken, Patricia M. Chen, Cheryl R. Clark, Sarah C. Kobrin, Jessica Chubak +6 more

Timing of Colposcopy and Risk of Cervical Cancer

Obstetrics and Gynecology(2023)10.1097/aog.0000000000005313
N/A
0DataRank · unranked
11 citations

Jacquelyn M. Lykken, Jasmin A. Tiro, Jessica Chubak, Aruna Kamineni, Jennifer Scarlet Haas +4 more

COVID-19 as a catalyst for reimagining cervical cancer prevention

eLife(2023)10.7554/elife.86266
N/A
0DataRank · unranked
8 citations

Sarah Feldman, Yin Ling Woo, Anna‐Barbara Moscicki, Anna R. Giuliano, Sílvia de Sanjosé +10 more